Robert Chong • UCLA Profiles (original) (raw)

  1. Clinical and radiographic prognostic factors in recurrent contrast-enhancing IDH-mutant gliomas treated with bevacizumab. Neurooncol Adv. 2026 Jan-Dec; 8(1):vdag089. Le CT, Sanvito F, Yang C, Eldred BSC, Raymond C, Prins TJ, Fisher A, Li T, Liau LM, Chong RA, Nghiemphu PL, Cloughesy TF, Lai A, Ellingson BM. PMID: 42046772; PMCID: PMC13110796.
    View in: PubMed Mentions:
  2. MGMT downregulation by CRISPR/Cas13 RNA-guided RNA targeting enhances glioma cell sensitivity to TMZ chemotherapy. J Neurooncol. 2026 Mar 12; 177(1). Prins TJ, Lai TJ, Li T, Fisher A, Eldred BSC, Mostafavi R, Liau LM, Chong RA, Nghiemphu PL, Cloughesy TF, Nathanson DA, Lai A. PMID: 41817895; PMCID: PMC12982228.
    View in: PubMed Mentions: Fields:
  3. Impact of corticosteroid administration on contrast-enhancing volume and diffusion MRI in treatment naïve glioblastoma. Neuro Oncol. 2025 Nov 01; 27(11):3016-3026. Sanvito F, Kim A, Raymond C, Teraishi A, Everson RG, Nghiemphu PL, Lai A, Chong RA, Nathanson DA, Salamon N, Cloughesy TF, Yao J, Ellingson BM. PMID: 40443040; PMCID: PMC12908483.
    View in: PubMed Mentions: Fields:
    Translation:Humans
  4. First-in-human study of an EGFRvIII x CD3 T cell bispecific antibody in the treatment of newly diagnosed glioblastoma. Neurooncol Adv. 2025 Jan-Dec; 7(1):vdaf160. Whittle JR, Vieito M, Rohrberg K, Rodriguez-Ruiz ME, Castanon E, Mellinghoff IK, Van Linde M, Cloughesy T, Reardon DA, Chong RA, Rosenthal M, Wick A, Waldhauer I, Henkel N, Romagnoli B, Wolowski V, Dey S, Heil F, Heichinger C, Flinn N, Gou JP, Smith L, Prince F, Derks M, Roller A, Schiff C, Schneider M, Mason W. PMID: 40842640; PMCID: PMC12365897.
    View in: PubMed Mentions:
  5. A comparative study of preclinical and clinical molecular imaging response to EGFR inhibition using osimertinib in glioblastoma. Neurooncol Adv. 2025 Jan-Dec; 7(1):vdaf022. Ellingson BM, Okobi Q, Chong R, Plawat R, Zhao E, Gafita A, Sonni I, Chun S, Filka E, Yao J, Telesca D, Li S, Li G, Lai A, Nghiemphu P, Czernin J, Nathanson DA, Cloughesy TF. PMID: 40051661; PMCID: PMC11883343.
    View in: PubMed Mentions: 2
  6. A single-institution retrospective analysis of pathologically determined malignant transformation in IDH mutant glioma patients. Neurooncol Adv. 2023 Jan-Dec; 5(1):vdad036. Liu V, Wetzel EA, Eldred BSC, Zapanta Rinonos S, Prins TJ, Khanlou N, Liau LM, Chong R, Nghiemphu PL, Cloughesy TF, Ellingson BM, Lai A. PMID: 37152809; PMCID: PMC10162112.
    View in: PubMed Mentions: 3
  7. Retrospective examination of pseudoprogression in IDH mutant gliomas. Neurooncol Adv. 2023 Jan-Dec; 5(1):vdad028. Wetzel EA, Farrell MJ, Eldred BSC, Liu V, Saha I, Zapanta Rinonos S, Prins T, Li T, Cao M, Hegde J, Kaprealian T, Khanlou N, Liau LM, Nghiemphu PL, Cloughesy TF, Chong RA, Ellingson BM, Lai A. PMID: 37128507; PMCID: PMC10148681.
    View in: PubMed Mentions: 3
  8. MELAS: Monitoring treatment with magnetic resonance spectroscopy. Acta Neurol Scand. 2019 Jan; 139(1):82-85. Hovsepian DA, Galati A, Chong RA, Mazumder R, DeGiorgio CM, Mishra S, Yim C. PMID: 30216413.
    View in: PubMed Mentions: 10 Fields:
    Translation:Humans
  9. Suramin inhibits cullin-RING E3 ubiquitin ligases. Proc Natl Acad Sci U S A. 2016 Apr 05; 113(14):E2011-8. Wu K, Chong RA, Yu Q, Bai J, Spratt DE, Ching K, Lee C, Miao H, Tappin I, Hurwitz J, Zheng N, Shaw GS, Sun Y, Felsenfeld DP, Sanchez R, Zheng JN, Pan ZQ. PMID: 27001857; PMCID: PMC4833235.
    View in: PubMed Mentions: 31 Fields:
  10. Pivotal role for the ubiquitin Y59-E51 loop in lysine 48 polyubiquitination. Proc Natl Acad Sci U S A. 2014 Jun 10; 111(23):8434-9. Chong RA, Wu K, Spratt DE, Yang Y, Lee C, Nayak J, Xu M, Elkholi R, Tappin I, Li J, Hurwitz J, Brown BD, Chipuk JE, Chen ZJ, Sanchez R, Shaw GS, Huang L, Pan ZQ. PMID: 24912152; PMCID: PMC4060658.
    View in: PubMed Mentions: 19 Fields:
    Translation:HumansCells
  11. Late-onset bacteremia in uncomplicated pediatric liver-transplant recipients after a febrile episode. Transpl Int. 2002 Oct; 15(9-10):502-7. Quirós-Tejeira RE, Ament ME, McDiarmid SV, Gonzalez M, Chong R, Vargas JH, Martín MG. PMID: 12389083.
    View in: PubMed Mentions: 1 Fields:
    Translation:Humans

This graph shows the number and percent of publications by field. Fields are based on how the National Library of Medicine (NLM) classifies the publications' journals and might not represent the specific topics of the publications. Note that an individual publication can be assigned to more than one field. As a result, the publication counts in this graph might add up to more than the number of publications the person has written. To see the data as text, click here.

This graph shows the number and percent of publications by field. Fields are based on how the National Library of Medicine (NLM) classifies the publications' journals and might not represent the specific topics of the publications. Note that an individual publication can be assigned to more than one field. As a result, the publication counts in this graph might add up to more than the number of publications the person has written. To see the data as text, click here.

Start with: newest oldestInclude: line numbers double spacing all authors publication IDs